ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly Press release Companies will collaborate to develop editing oligonucleotides directed to up to five targets using ProQR’s proprietary Axiomer® RNA edit Setembro 08, 2021
ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer Press release LEIDEN, the Netherlands, Feb. 27, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Fevereiro 27, 2018
ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference Press release … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About … Outubro 24, 2017
ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott Armstrong Press release Key Updates Agosto 28, 2017
ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10 Press release Key Updates Maio 31, 2017
ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates Press release … co-founder of ProQR and previously served as ProQR’s Chief Innovation Officer from 2014 to 2022. John Maraganore, PhD, a … Junho 01, 2022
ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Dezembro 05, 2024
Lilly and ProQR to Expand RNA Editing Collaboration Press release New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology Dezembro 22, 2022
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day Press release LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Janeiro 29, 2019
ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness Press release … candidates and the timing thereof, including those in our innovation pipeline. Our actual results could differ … Novembro 13, 2017